China Pharma Holdings CPHI
NYSE CPHI
$0.65 0.00 (-0.46%)
As of: Sep 30, 2026 · 3:59 PM EDT

China Pharma Holdings (CPHI) Liabilities and Shareholders Equity (2010 - 2026)

Updated

China Pharma Holdings (CPHI) recorded Liabilities and Shareholders Equity of $44.71 million in Q2 2026, up 224.8% from $13.77 million a year earlier but down 1.0% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, China Pharma Holdings reported Liabilities and Shareholders Equity of $31 million, up 108.2% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $14.89 million in FY2024 (-9.6%), $16.47 million in FY2023 (-7.4%), $17.78 million in FY2022 (-21.5%) and $22.65 million in FY2021 (+7.3%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $13.47 million in Q3 2024 to $45.14 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased for four consecutive quarters, with growth averaging 66.3% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 224.8% in Q2 2026, against a decline of 21.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $45.14 million (Q1 2026), $31 million (Q4 2025) and $15.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 201.06 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 135.12 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 115.83 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 27.42 Bn
10 China Pharma Holdings 27.15 Mn 26.03 Mn 83,566.00 44.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.71 Mn
Mar 31, 2026 45.14 Mn
Dec 31, 2025 31.00 Mn
Sep 30, 2025 15.80 Mn
Jun 30, 2025 13.77 Mn
Mar 31, 2025 14.22 Mn
Dec 31, 2024 14.89 Mn
Sep 30, 2024 13.47 Mn
Jun 30, 2024 14.26 Mn
Mar 31, 2024 16.19 Mn
Dec 31, 2023 16.47 Mn
Sep 30, 2023 15.35 Mn
Jun 30, 2023 15.70 Mn
Mar 31, 2023 17.36 Mn
Dec 31, 2022 17.78 Mn
Sep 30, 2022 16.20 Mn
Jun 30, 2022 17.92 Mn
Mar 31, 2022 21.04 Mn
Dec 31, 2021 22.65 Mn
Sep 30, 2021 18.18 Mn
API Access

China Pharma Holdings Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CPHI&period=max&api_key=YOUR_API_KEY